Evidence map›Paper›PMID 20194292›Full record

ArticleHypertension (Dallas, Tex. : 1979)2010

Erythropoietin increases expression and function of vascular copper- and zinc-containing superoxide dismutase.

Livius V d'Uscio, Leslie A Smith, Zvonimir S Katusic

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Inactivation of BACE1 increases expression of endothelial nitric oxide synthase in cerebrovascular endothelium.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Protecting against vascular disease in brain.American journal of physiology. Heart and circulatory physiology · 2011
    Review
  13. Cardiovascular effects of erythropoietin an update.Advances in pharmacology (San Diego, Calif.) · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Livius V d'UscioDepartmentsof Anesthesiology and Molecular Pharmacology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Leslie A Smith
Zvonimir S Katusic
Mayo Clinic · US

Funding

TETRAHYDROBIOPTERIN--REGULATOR OF ENDOTHELIAL FUNCTIONR01HL053524 · NHLBI · MAYO CLINIC ROCHESTER · PI KATUSIC, ZVONIMIR S · 1995 to 2009
$2.3M
Mechanisms of endothelial repair after vascular injuryR01HL091867 · NHLBI · MAYO CLINIC ROCHESTER · PI KATUSIC, ZVONIMIR S · 2009 to 2012
$1.5M
NHLBI NIH HHS HL-53524NHLBI NIH HHS HL91867NHLBI NIH HHS R01 HL053524NHLBI NIH HHS R01 HL091867
6 · The paper itself

Abstract

Previous studies have shown that treatment with erythropoietin (EPO) exerts vascular protective effects. The exact mechanisms responsible for these effects are not completely understood. In the present study, we hypothesized that EPO stimulates expression and activity of copper- and zinc-containing superoxide dismutase (SOD1), thus protecting vascular tissue from oxidative stress induced by excessive concentrations of superoxide anions. EPO treatment of wild-type mice for 2 weeks (1000 U/kg, SC, biweekly) significantly increased aortic expression of SOD1. This effect resulted in a significant reduction of superoxide anion concentrations in aorta of treated mice. The ability of EPO to reduce vascular production of superoxide anions was abolished in SOD1-deficient mice. In a mouse model of wire-induced injury of the common carotid artery, treatment of wild-type mice with EPO prevented pathological remodeling, whereas the vascular effect of EPO was absent in SOD1-deficient mice. Our findings demonstrate that treatment with EPO increases vascular expression of SOD1. This effect appears to be an important molecular mechanism underlying vascular protection by EPO.

Indexed as

Analysis of VarianceAnimalsAortaBlotting, WesternCatalaseCell CountChromatography, High Pressure LiquidEndothelium, VascularErythropoietinHydrogen PeroxideMaleMiceMice, KnockoutNeovascularization, PathologicOxidative StressPhosphorylationCatalaseErythropoietinHydrogen PeroxideProto-Oncogene Proteins c-aktSuperoxide DismutaseSuperoxides

Identifiers

PMID20194292
PMCPMC2872070
OpenAlexW2153935901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.